Pim-1 activation of cell motility induces the malignant phenotype of tongue carcinoma

Molecular Medicine Reports

Volumn 2, Issue 2, 2009, Pages 313-318

  Tanaka, Souichi ^a   Kitamura, Tetsuya ^a   Higashino, Fumihiro ^a   Hida, Kyoko ^a   Ohiro, Yoichi ^a   Ono, Mitsunobu ^a   Kobayashi, Masanobu ^b   Totsuka, Yasunori ^a   Shindoh, Masanobu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Metastasis; Motility; Pim 1. Rac1; Tongue carcinoma

Indexed keywords

GUANOSINE TRIPHOSPHATE; PROTEIN KINASE PIM 1; RAC1 PROTEIN; RHO FACTOR; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; BINDING ASSAY; CARCINOGENESIS; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PHENOTYPE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; WESTERN BLOTTING;

EID: 69249145630     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000102     Document Type: Article

References (34)

1. Kudo Y, Kitajima S, Ogawa I, Miyauchi M and Takata T: Downregulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 41: 105-116, 2005.
2. Choi S and Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32, 2008.
3. Hunter KD, Parkinson EK and Harrison PR: Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135, 2005.
4. Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C and Berns A: Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37: 141-150, 1984.
5. Tsichlis PN: Oncogenesis by Moloney murine leukemia virus. Anticancer Res 7: 171-180, 1987.
6. Padma R and Nagarajan L: The human PIM-1 gene product is a protein serine kinase. Cancer Res 51: 2486-2489, 1991.
7. Mochizuki T, Kitanaka C, Noguchi K, Muramatsu T, Asai A and Kuchino Y: Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem 274: 18659-18666, 1999.
8. Zhang Y, Wang Z and Magnuson NS: Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells. Mol Cancer Res 5: 909-922, 2007.
9. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ and Kraft A: The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 18: 4022-4031, 1999.
10. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M and Koskinen PJ: Pim-1 kinase promotes inactivation of the proapoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 571: 43-49, 2004.
11. Koizumi K, Hojo S, Akashi T, Yasumoto K and Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 98: 1652-1658, 2007.
12. Pawelek JM: Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6: 988-993, 2005.
13. Fukata M, Nakagawa M and Kaibuchi K: Roles of Rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol 15: 590-597, 2003.
14. Watanabe T, Noritake J and Kaibuchi K: Regulation of microtubules in cell migration. Trends Cell Biol 15: 76-83, 2005.
15. Selten G, Cuypers HT, Zijlstra M, Melief C and Berns A: Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J 3: 3215-3222, 1984.
16. Breuer M, Slebos R, Verbeek S, van Lohuizen M, Wientjens E and Berns A: Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 340: 61-63, 1989.
17. Wang Z, Bhattacharya N, Mixter PF, Wei W, Sedivy J and Magnuson NS: Phosphorylation of the cell cycle inhibitor p21(Cip1/WAF1) by Pim-1 kinase. Biochim Biophys Acta 1593: 45-55, 2002.
18. Stone DM, Norton LK, Magnuson NS and Davis WC: Elevated pim-1 and c-myc proto-oncogene induction in B lymphocytes from BLV-infected cows with persistent B lymphocytosis. Leukemia 10: 1629-1638, 1996.
19. Van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T and Berns A: Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56: 673-682, 1989.
20. Cibull TL, Jones TD, Li L, Eble JN, Ann Baldridge L, Malott SR, Luo Y and Cheng L: Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol 59: 285-288, 2006.
21. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV and Sawyers CL: Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4: 223-238, 2003.
22. Xu Y, Zhang T, Tang H, Zhang S, Liu M, Ren D and Niu Y: Overexpression of PIM-1 is a potential biomarker in prostate carcinoma. J Surg Oncol 92: 326-330, 2005.
23. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
24. Woodhouse EC, Chuaqui RF and Liotta LA: General mechanisms of metastasis. Cancer 80: 1529-1537, 1997.
25. Mehlen P and Puisieux A: Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458, 2006.
26. Onken MD, Worley LA and Harbour JW: A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 14: 3737-3745, 2008.
27. Zijlstra A, Lewis J, Degryse B, Stuhlmann H and Quigley JP: The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13: 221-234, 2008.
28. Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, Ono M, Kohgo T, Nakamura M, Notani K, Fukuda H, Totsuka Y, Yoshida K and Fujinaga K: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21: 1079-1085, 2000.
29. Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, Fujinaga K and Nishimura M: Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int J Cancer 93: 786-791, 2001.
30. Recio JA and Merlino G: Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21: 1000-1008, 2002.
31. Sahai E and Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142, 2002.
32. Schafer DA, Welch MD, Machesky LM, Bridgman PC, Meyer SM and Cooper JA: Visualization and molecular analysis of actin assembly in living cells. J Cell Biol 143: 1919-1930, 1998.
33. Allen WE, Jones GE, Pollard JW and Ridley AJ: Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 110: 707-720, 1997.
34. Azuma T, Witke W, Stossel TP, Hartwig JH and Kwiatkowski DJ: Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J 17: 1362-1370, 1998.